Asia Bio Partnering Forum begins in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Singapore
September 1–2, 2026Marina Bay Sands Jeff LinPartner at iGlobe PartnersSpeaker
Profile
Jeff Lin is a Partner at iGlobe Partners, a Singapore-based venture capital firm focused on cross-border deep tech and healthcare investments. Since joining the firm in early 2014, Jeff has led and managed investments across synthetic biology, medical devices, therapeutics, diagnostics, and AI. His notable portfolio companies include Orbital Therapeutics (acquired by Bristol Myers Squibb), Accession Therapeutics, C2i Genomics (acquired by Veracyte), and Twist Bioscience. Previously, Jeff built extensive industry experience across strategy consulting and the TMT sector. He is an alumnus of the University of Science and Technology of China and INSEAD/Wharton.
Agenda Sessions
Expanding into EMEA: Where APAC Medtech Actually Wins (and Fails)
, 13:30View Session